Hin Sang Group (International)'s (HKG:6893) loss widened to HK$49.4 million in the year ended March 31 from HK$36.7 million in fiscal 2024, according to an annual report filed Thursday with the Hong Kong bourse.
Loss per share at the healthcare and household products company widened to HK$0.0452 from HK$0.0336 in the previous fiscal year.
Revenue slipped 0.8% to HK$91.9 million from HK$92.6 million a year earlier.